CeriBell, Inc.
NASDAQ:CBLLMedical - Devices
+$0.25 today
- Market cap
- $995.34M
- Beta
- 0.84
- P/E (TTM)
- -10.9
- EPS (TTM)
- -$1.60
Volume 0.41M
Average 0.29M
CBLL Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
CeriBell, Inc.NASDAQ: CBLL
Gross Profit · Q1 FY2026 · quarter ended Mar 2026
Gross profit grows, but more slowly than its trailing trend
Q1 FY2026 gross profit of $23.12M rose 28.4% year over year, behind the +34.5% change in trailing-twelve-month gross profit. Sequentially, it rose 6.8% from the prior quarter. Over 3 fiscal years it compounded at +53.9% a year.
Context
- Gross profit amounted to 87.9% of revenue in FY2025, up 1.2 pp from a year earlier.
- Gross profit increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +28.4% toward the trailing-twelve-month pace of +34.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 78.27M USD
- Year-over-year change
- +37.9%
- 3-year CAGR
- +53.9%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 78.27M | +37.9% |
| FY2024 | 2024-12-31 | 56.75M | +48.7% |
| FY2023 | 2023-12-31 | 38.16M | +77.6% |
| FY2022 | 2022-12-31 | 21.49M | — |
Gross Profit vs competitors
How CBLL compares with its peers on the latest reported figures
- CBLL's LTM Mar 2026 gross profit of $83.39M is the 2nd highest of the 7 companies compared; the peer median is $61.62M.
- Its year-over-year change of +34.5% is the 2nd highest of 7, against a peer median of +25.8%.
- Gross profit amounts to 87.7% of revenue for CBLL, versus a peer median of 76.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.02B | +10.7% | +9.9% | 67.9% | |
CBLLCeriBell, Inc. | LTM Mar 2026 | $83.39M | +34.5% | +53.9% | 87.7% |
| LTM Mar 2026 | $77.93M | +23.5% | +33.4% | 78.3% | |
| LTM Mar 2026 | $72.72M | +28.0% | +13.3% | 48.0% | |
| LTM Mar 2026 | $50.52M | +14.2% | +40.4% | 85.5% | |
| LTM Mar 2026 | $42.45M | +31.1% | +25.2% | 75.5% | |
| LTM Mar 2026 | $30.45M | +35.0% | +58.5% | 87.2% | |
| Peer median (excluding CBLL) | $61.62M | +25.8% | +29.3% | 76.9% | |
Competitors are the stored peer set for CBLL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 25.92M | 45.23M | 65.44M | 89.06M |
| Cost of Revenue | 4.43M | 7.06M | 8.69M | 10.79M |
| Gross Profit | 21.49M | 38.16M | 56.75M | 78.27M |
| Gross Margin | 82.9% | 84.4% | 86.7% | 87.9% |
| Research & Development | 7.24M | 9M | 13.56M | 19.14M |
| Selling, General & Admin | 50.27M | 59.21M | 82.9M | 117.53M |
| Operating Expenses | 57.51M | 68.2M | 96.46M | 136.68M |
| Depreciation & Amortization | 497K | 847K | 1.14M | 1.34M |
| EBITDA | (35.06M) | (26.51M) | (37.32M) | (50.18M) |
| EBITDA Margin | -135.3% | -58.6% | -57.0% | -56.3% |
| Operating Income | (36.02M) | (30.04M) | (39.71M) | (58.4M) |
| Operating Margin | -139.0% | -66.4% | -60.7% | -65.6% |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 1.6M | 2.1M | 1.99M | 1.89M |
| Other Income / Expenses | (1.14M) | 588K | (746K) | 4.99M |
| Income Before Tax | (37.16M) | (29.45M) | (40.46M) | (53.41M) |
| Pre-Tax Margin | -143.4% | -65.1% | -61.8% | -60.0% |
| Income Tax Expense | 2K | 11K | 0 | 0 |
| Net Income | (37.16M) | (29.46M) | (40.46M) | (53.41M) |
| Net Margin | -143.4% | -65.1% | -61.8% | -60.0% |
| EPS (Basic) | (1.59) | (1.26) | (3.39) | (1.46) |
| EPS (Diluted) | (1.59) | (1.26) | (3.39) | (1.46) |
| Weighted Avg Shares | 23.32M | 23.32M | 11.95M | 36.54M |
| Weighted Avg Shares (Diluted) | 23.32M | 23.32M | 11.95M | 36.54M |
CeriBell, Inc.
NASDAQ:CBLL
Intrinsic Alpha fair value
Locked
Current Price
$25.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.